Skip to main content
v2026.11,986 entries · CC-BY 4.0

NotI Restriction Enzyme: Cleavage Site & Uses

NotI is an 8-bp rare-cutting restriction enzyme recognizing 5′-GCGGCCGC-3′. Learn cleavage kinetics, CpG methylation sensitivity, and lab cloning protocols.

Written and maintained by CASRAI Editorial Board

Published · Last updated

On this page

Short answer

NotI is a rare-cutting Type II restriction endonuclease isolated from Nocardia otitidiscaviarum. It recognizes the 8-base-pair palindrome 5′-GCGGCCGC-3′ and cleaves after the first guanine, generating 4-base 5′ cohesive overhangs. Due to extreme CpG suppression in mammalian genomes, NotI cuts infrequently, making it essential for macro-restriction mapping, pulsed-field gel electrophoresis, and directional molecular cloning.

Definition and scope

NotI (frequently transcribed in laboratory literature and search catalogs as not1 or not 1) is an octanucleotide-recognizing Type IIP restriction endonuclease. Named under the Smith-Nathans convention from the actinobacterium Nocardia otitidiscaviarum, NotI targets an unmethylated 8-base-pair symmetrical palindrome rather than the 4-bp or 6-bp sequences recognized by standard restriction endonucleases:

5'-G C ^ G G C C G C-3'
3'-C G C C G G ^ C G-5'

Cleavage occurs between the 5′-cytosine and adjacent guanine on both antiparallel strands, leaving a 4-nucleotide 5′ cohesive extension (5′-GGCC…-3′). In random DNA with balanced base composition (50% GC), an 8-bp site occurs once every 65,536 base pairs ($4^8$). In mammalian genomes, however, NotI cleaves on average only once every 1,000,000 to 1,500,000 base pairs because mammalian DNA is GC-deficient (~41% GC) and severely depleted of the CpG dinucleotide motif.

How it works or how it is used in practice

NotI functions as a homodimer requiring divalent magnesium ions (Mg²⁺) to catalyze phosphodiester bond hydrolysis. Its practical application requires attention to reaction kinetics, buffer conditions, and DNA substrate geometry.

Recognition Sequence and Cleavage at the NotI Site

The canonical noti site consists of eight alternating guanine and cytosine base pairs with twofold rotational symmetry. Cleavage yields 5′-GGCC cohesive overhangs compatible with isocaudomers such as EagI. Because the site contains two CpG dinucleotides, cleavage is governed directly by host methylation status.

Reaction Conditions and Buffer Optimization

Standard digestions follow specific manufacturer guidelines:

  • Buffer Selection: Standard NotI functions optimally in high-salt buffers (NEBuffer r3.1: 100 mM NaCl, 50 mM Tris-HCl, 10 mM MgCl2, 100 µg/ml Recombinant Albumin, pH 7.9 at 25°C). High-fidelity variants (NotI-HF) utilize universal rCutSmart buffer.
  • Incubation Temperature: Digestion proceeds at 37°C.
  • Glycerol Limits: Glycerol in the final reaction mixture must stay below 5% (v/v) to prevent off-target star activity during prolonged incubation.
  • Heat Inactivation: Incubation at 65°C for 20 minutes completely inactivates NotI, permitting subsequent enzymatic steps without DNA purification.

For multi-enzyme digests, refer to standard protocols for restriction enzyme digest setup.

Cleavage Close to the End of DNA Fragments

When engineering NotI sites into PCR primers for cloning, terminal DNA padding is required. Published data from New England Biolabs indicates that NotI cleavage drops below 10–20% when fewer than 3 base pairs flank the recognition sequence. Designing at least 6 to 8 flanking nucleotides 5′ to the NotI site ensures cleavage efficiency above 90%.

CpG Methylation Sensitivity

NotI is completely blocked when internal cytosine residues are modified to 5-methylcytosine (5mC) by mammalian DNA methyltransferases (DNMT1, DNMT3A, DNMT3B) or CpG methylases:

5'-G C (5mC) G G C C G C-3' (Cleavage Blocked)

Bacterial Dam (GATC) and Dcm (CCAGG/CCTGG) methylations do not affect NotI. Because CpG islands at active mammalian promoters are hypomethylated, NotI selectively digests transcriptionally active regions.

Rare-cutting endonucleases differ by recognition length, nucleotide composition, and overhang structure. The table below compares NotI with related rare-cutting and GC-rich enzymes used in molecular mapping.

Enzyme Recognition Sequence Overhang Frequency (50% GC) Methylation Sensitivity Primary Application
NotI 5′-GC^GGCCGC-3′ 4-nt 5′ (GGCC) 1 in 65,536 bp Blocked by CpG PFGE mapping, BAC/YAC cloning, CpG island analysis
SfiI 5′-GGCCNNNN^NGGCC-3′ 3-nt 3′ (variable) 1 in 65,536 bp Blocked by CpG (site-dependent) Directional cDNA cloning without self-ligation
AscI 5′-GG^CGCGCC-3′ 4-nt 5′ (CGCG) 1 in 65,536 bp Blocked by CpG Vector linearization, large construct assembly
FseI 5′-GGCCGG^CC-3′ 4-nt 3′ (GGCC) 1 in 65,536 bp Blocked by CpG Mammalian genomic restriction, cassette exchange
PacI 5′-TTAAT^TAA-3′ 2-nt 3′ (TA) 1 in 65,536 bp Unaffected by CpG AT-rich genome digestion, rare-site cloning
EagI 5′-C^GGCCG-3′ 4-nt 5′ (GGCC) 1 in 4,096 bp Blocked by CpG Generating compatible cohesive ends for NotI inserts

Where it matters for labs, clinics or supply decisions

NotI provides distinct utility across research and diagnostic applications:

  1. Pulsed-Field Gel Electrophoresis (PFGE): In epidemiological surveillance and bacterial typing, frequent cutters produce unresolvable smears. NotI yields 15 to 30 megabase-sized fragments (50 kb to over 1 Mb) that resolve clearly on pulsed-field gels.
  2. Large-Insert Vector Cloning: In BAC, PAC, and cosmid systems, NotI flanking sites within the multiple cloning site (MCS) allow excision of intact genomic inserts without internal cleavage. Construct validation relies on detailed plasmid map verification.
  3. Epigenetic Diagnostics: Because NotI cleaves only unmethylated CpG islands, combining NotI digestion with Southern blot analysis or PCR identifies promoter hypermethylation linked to tumor suppressor silencing in cancer biology.
  4. Enzyme Formulation Choices: For extended overnight digestions, labs often choose high-fidelity NotI-HF over standard NotI to eliminate star activity and simplify multi-enzyme workflows in universal buffer.

Common misunderstandings

  • Assuming NotI cuts every 65 kb in human DNA: While 8-bp sites occur statistically every 65,536 bp in random 50% GC sequences, evolutionary CpG depletion in mammalian DNA reduces actual cleavage to once every 1.0 to 1.5 megabases.
  • Designing PCR primers without flanking bases: Placing a NotI site at the extreme terminus of a PCR primer without 6 to 8 non-specific flanking bases causes near-complete cleavage failure due to poor enzyme binding.
  • Expecting NotI to digest native eukaryotic tissue DNA completely: Native mammalian DNA contains widespread CpG methylation that blocks NotI cleavage. Complete cleavage occurs only at unmethylated loci or on unmethylated PCR amplifications.
  • Confusing NotI with not1 or logical operators: The informal designations not1 or not 1 reflect spoken Roman numerals rather than computer logic syntax.

FAQ

Why is NotI often written as not1 or not 1?

Restriction enzyme nomenclature uses Roman numerals. Because “I” resembles the digit “1” and is pronounced “Not-one”, catalogs and lab records frequently use the informal designations not1 or not 1.

What sequence does the NotI restriction site recognize?

The NotI site is the palindromic octanucleotide 5′-GCGGCCGC-3′. Cleavage occurs between the first and second guanine residues, leaving a 4-base 5′ cohesive overhang (5′-GGCC-3′).

Why does NotI cut so rarely in mammalian genomes?

Mammalian genomes have low GC content (~41%) and severe evolutionary CpG suppression (roughly one-quarter of expected frequency). Because NotI requires an 8-bp G+C sequence containing two CpG motifs, cleavage sites average 1.0 to 1.5 megabases apart.

Can NotI cleave PCR products lacking flanking nucleotides?

No. When a NotI site is within 1 to 3 base pairs of a linear DNA end, cleavage efficiency is severely reduced. Primers must incorporate at least 6 to 8 flanking bases 5′ to the site.

Does DNA methylation inhibit NotI digestion?

Yes. CpG methylation (5-methylcytosine) completely blocks NotI cleavage. Dam and Dcm methylations do not affect the enzyme because the recognition site lacks their target motifs.

How is NotI heat-inactivated in the laboratory?

NotI is inactivated by incubation at 65°C for 20 minutes, allowing downstream reactions without DNA column purification.

Sources

  • Qiang, B.-Q., and Schildkraut, I. (1987). “NotI and SfiI: restriction endonucleases with octanucleotide recognition sequences.” Methods in Enzymology, Vol. 155, pp. 15–21. doi:10.1016/0076-6879(87)55005-7. Read 2026-11-10.
  • Roberts, R. J., Vincze, T., Posfai, J., and Macelis, D. REBASE: The Restriction Enzyme Database. Enzyme Entry: NotI. https://rebase.neb.com/rebase/enz/NotI.html. Read 2026-11-10.
  • New England Biolabs. NotI (Cat #R0189) and NotI-HF (Cat #R3189) Specifications, Buffer Requirements, and Cleavage Close to the End of DNA Fragments. https://www.neb.com/en-us/products/r0189-noti. Read 2026-11-10.
  • Thermo Fisher Scientific. FastDigest NotI (Cat #FD0593) Product Data Sheet and Universal Buffer Digestion Protocol. https://www.thermofisher.com/order/catalog/product/FD0593. Read 2026-11-10.

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Ask CASRAI · full access

Ask about NotI Restriction Enzyme: Cleavage Site & Uses

Full access: large monthly usage, up to 10 source passages behind each answer, and MCP and API access for Claude Code, Codex and other CLIs. Cancel any time.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →